Orchid Chemicals & Pharmaceuticals Ltd (ORCHIDCHEM) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 21 PAGES: 32

Orchid Chemicals & Pharmaceuticals Ltd (Orchid) is a pharmaceutical company, based in India. The company develops and manufactures active pharmaceutical ingredients (APIs) and finished dosage forms as well as involved in drug discovery. Its research and development (R&D) efforts include advanced chemical research and analytical development as well as modern formulations development. The company’s research programs are categorized in the areas of process research, pharma research, new drug discovery (NDD), pre-clinical research, novel drug delivery systems (NDDS), biotech research and intellectual property management (IPR). It has six subsidiaries located in Japan, India, South Africa, South America, the UK and the US. The company operates through its two manufacturing facilities located in Chennai and Aurangabad, which produces APIs, as well as three sites for dosage forms at Irungattukottai and Alathur in Chennai. Orchid is headquartered in Chennai, Tamil Nadu, India.

More Info
									           Orchid Chemicals & Pharmaceuticals Ltd (ORCHIDCHEM) - Financial
                         and Strategic SWOT Analysis Review
        Reference Code: GDPH63309FSA                                                                                          Publication Date: AUG 2012

          Orchid Towers, #313, Valluvar Kottam
                                                             Phone              +91 44 28211000                 Revenue          19,020.52 (million INR)
          High Road, Nungambakkam
          Chennai, Tamil Nadu                                Fax                +91 44 28211002                 Net Profit       974.78 (million INR)
          600034                                             Website            www.orchidpharma.com            Employees        4,500
                                                                                ORCHIDCHEM
                                                                                                                                 Pharmaceuticals           &
          India                                              Exchange           [National          Stock        Industry
                                                                                                                                 Healthcare
                                                                                Exchange of India]

       Company Overview
       Orchid Chemicals & Pharmaceuticals Ltd (Orchid) is a pharmaceutical company, based in India. The company develops and
       manufactures active pharmaceutical ingredients (APIs) and finished dosage forms as well as involved in drug discovery. Its
       research and development (R&D) efforts include advanced chemical research and analytical development as well as modern
       formulations development. The company’s research programs are categorized in the areas of process research, pharma
       research, new drug discovery (NDD), pre-clinical research, novel drug delivery systems (NDDS), biotech research and intellectual
       property management (IPR).
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Orchid Chemicals & Pharmaceuticals Ltd, SWOT Analysis
         K Raghavendra Rao                   Chairman                                 Strengths                              Weaknesses
         S Krishnan                          Director, Finance
                                                                                      Strong Manufacturing                   Increasing Costs affecting
         Dr. B Gopalan                       Director                                 Infrastructure                         Margins
         Deepak Vaidya                       Director
                                                                                      R&D Capabilities
         Bharat D. Shah                      Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                          Threats

       Share Data                                                                     Approvals and Products                 Uncertain R&D Outcomes
         Orchid Chemicals & Pharmaceuticals Ltd                                       Pipeline
                                                                                                                             Competitive Landscape
        Share Price (INR) as on 10-Aug-                               107.50          Strategic Initiatives
        2012
        EPS (INR)                                                        2.45
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        Market Cap (million INR)                                       7,706         GlobalData

        Enterprise Value (million INR)                                22,210
        Shares Outstanding (million)                                       70
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      May 14, 2012         Orchid Pharma Reports Revenue Of INR18.4
                                                                                                           Billion In Fiscal 2012
                                                                                      Feb 08, 2012         Orchid Pharma Reports Revenue Of $94m In
                                                                                                           Q3 Fiscal 2012
                                                                                      Dec 20, 2011         Orchid's Drug Discovery Program With Merck
                                                                                                           Meets Preclinical Milestone
                                                                                      Nov 01, 2011         Orchid Pharma Reports Net Sales Of INR4.1
                                                                                                           Billion In Q2 Fiscal 2012
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Orchid Chemicals & Pharmaceuticals Ltd (ORCHIDCHEM) -                                                                          Reference Code: GDPH63309FSA
Financial and Strategic SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 4
       Orchid Chemicals & Pharmaceuticals Ltd - Key Facts ....................................................................................................................... 4
       Orchid Chemicals & Pharmaceuticals Ltd - Key Employees .............................................................................................................. 5
       Orchid Chemicals & Pharmaceuticals Ltd - Major Products and Services ......................................................................................... 6
       Orchid Chemicals & Pharmaceuticals Ltd - Pharmaceutical Pipeline Products Data ......................................................................... 8
          Orchid Chemicals & Pharmaceuticals Ltd, Pipeline Products by Therapy Area.............................................................................. 8
          Orchid Chemicals & Pharmaceuticals Ltd, Pipeline Products by Development Phase ................................................................... 9
       Orchid Chemicals & Pharmaceuticals Ltd - Locations And Subsidiaries .......................................................................................... 11
          Head Office ................................................................................................................................................................................... 11
          Other Locations & Subsidiaries ..................................................................................................................................................... 11
       Section 2 – Company Analysis ......................................................................................................................................................... 12
       Company Overview .......................................................................................................................................................................... 12
       Orchid Chemicals & Pharmaceuticals Ltd - SWOT Analysis ............................................................................................................ 13
          SWOT Analysis - Overview........................................................................................................................................................... 13
          Orchid Chemicals & Pharmaceuticals Ltd - Strengths .................................................................................................................. 13
            Strength - Strong Manufacturing Infrastructure ......................................................................................................................... 13
            Strength - R&D Capabilities ...................................................................................................................................................... 13
            Strength - Regulatory Filings and NCE Pipeline........................................................................................................................ 14
          Orchid Chemicals & Pharmaceuticals Ltd - Weaknesses ............................................................................................................. 14
            Weakness - Increasing Costs affecting Margins ....................................................................................................................... 14
          Orchid Chemicals & Pharmaceuticals Ltd - Opportunities ............................................................................................................ 14
            Opportunity - Approvals and Products Pipeline ......................................................................................................................... 14
            Opportunity - Strategic Initiatives .............................................................................................................................................. 14
            Opportunity - Growth Prospects: Indian Pharmaceutical Market ............................................................................................... 15
            Opportunity - Pharmaceutical Outsourcing Market Growth ....................................................................................................... 15
          Orchid Chemicals & Pharmaceuticals Ltd - Threats ..................................................................................................................... 15
           Threat - Uncertain R&D Outcomes ........................................................................................................................................
								
To top